BioCentury
ARTICLE | Analyst Picks & Changes

Analyst picks & changes

January 8, 1996 8:00 AM UTC

Industry overviews

Oppenheimer & Co. analyst Matthew Geller said selectivity will be the key to investing in biotech in 1996, and he warned that while certain stocks still have enormous upside potential, others could see a strong downturn this year. ...